Skip to main content
. 2009;29:74–78.

TABLE 1.

Patient Age/Gender Treatment Recurrence Disease free follow-up Neurologic Deficit
1 64F Resection None 4 years None

2 26F Curettage 1.5 years – 2 years None

3 39M Resection 6 years Curettage 6 months –Embolization & Curettage ? Giant Cell Tumor 2 years Bowel & Bladder Dysfunction

4 16 F Embolization & Curettage None 12 years None

5 32 M Curettage 2 Years –Embolization, Radiation, Resection 5 years None

6 60 F Mid-Sacral Amputation None 2 years None

7 57 M Embolization & Mid-Sacral Amputation 3.5 years –Curettage? Osteoblastoma 2 years Bowel Bladder Dysfunction

8 10 F Embolization & Curettage None 2 years None

9 5F Curettage None 2 years None

10 17 F Mid-Sacral Amputation None 2 years None